Elequin Capital’s Medtronic MDT Stock Holding History

Elequin Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,800	Closed	-$231K	–	385
2023 Q4	$231K	Buy	+2,800	New	+$213K	0.07%	107

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Elequin Capital's MDT Position: Q1 2024 in Review

Elequin Capital sold out of Medtronic (MDT) in Q1 2024, closing a stake of 2,800 shares — an estimated $231K sold.

Elequin Capital first reported a position in MDT in Q4 2023 and held it in 1 quarter. The position peaked at $231K in Q4 2023. 2,076 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

Elequin Capital reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
Elequin Capital sold 2,800 Medtronic shares in Q1 2024, an estimated $231K.
Elequin Capital first reported a position in Medtronic in Q4 2023 and held it in 1 quarter.
Elequin Capital's Medtronic position peaked at $231K in Q4 2023.
2,076 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Elequin Capital's 13F filing for Q1 2024, filed 15 May 2024.